Skip to main content

Table 3 Neopterin concentration (n = 18)

From: The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial

 

Treatment group 1 (n = 6)

Treatment group 2 (n = 6)

Control group (n = 6)

Cmax (ng/mL)

0.6183

4.333

0.7567

Tmax (h)

72

72

72

AUC (h·ng/mL)

40.3

328.6

63.95

AUC (h·nmol/L)

159

1298

253